High dose rate versus low dose rate brachytherapy in the treatment of tongue carcinoma - a radiobiological study.
Low dose rate (LDR) brachytherapy is a well established treatment for the early stages of tongue cancer. High dose rate (HDR) afterloading devices have replaced LDR brachytherapy in many radiotherapy departments, but the effect and safety of HDR brachytherapy in comparison with LDR brachytherapy for interstitial applications is an unresolved question. The aim of our radiobiological study was to utilize dose volume histiograms from patients treated in our institution to simulate the risk of complication of LDR and HDR brachytherapy. Normal tissue complication probabilities (NTCP) of acute mucositis, late mucosal necrosis and osteoradionecrosis of two HDR brachytherapy schedules (18 x 3 Gy bid and 10 x 6 Gy bid) and of LDR brachytherapy with identical tumor control probability were compared using data from 8 brachytherapy applications. A linear quadratic (LQ) model was used to calculate the biologically equivalent doses, the effective volume method of Kutcher and Burman and Lyman's model was used to calculate NTCP. The Student's two-tailed test was used for statistical analysis. For 18 x 3 Gy bid the risk of acute mucositis and of late mucosal necrosis was 1.48 and 1.66 times higher with HDR in comparison with LDR brachytherapy. For 10 x 6 Gy bid the risk of acute mucositis, mucosal necrosis and osteoradionecrosis was 1.3, 3.44 and 13.18 times higher with HDR brachytherapy. All differences were statistically highly significant. Our radiobiological study supported the hypothesis that HDR has a higher risk of complication in comparison with LDR brachytherapy for the same tumor control probability.


BACKGROUND
tongue cancer, brachytherapy, low dose rate, high dose rate.
Petera
J
J
Department of Oncology and Radiotherapy, University Hospital Hradec Králové, Czech Republic. petera@fnhk.cz
Matula
P
P
Paluska
P
P
Sirak
I
I
Macingova
Z
Z
Kasaova
L
L
Frgala
T
T
Hodek
M
M
Vosmik
M
M
D001918:Brachytherapy / Q000009:adverse effects / Q000379:methods; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D011879:Radiotherapy Dosage; D014062:Tongue Neoplasms / Q000532:radiotherapy*